Immune checkpoint inhibitors ICI (PD-1 and PD-L1 targeting drugs)
-
- Forum
- Topics
- Posts
- Last post
-
- 11 Topics
- 167 Posts
-
Last post
Re: Keytruda in Canada - Max …
by Olga View the latest post
-
- 10 Topics
- 111 Posts
-
Last post
Re: Hyponatraemia secondary t…
by D.ap View the latest post
-
- 3 Topics
- 18 Posts
-
Last post
Re: Elisa on Atezolizumab + B…
by D.ap View the latest post
-
-
Toxicity, problems and potentiation strategies
how not to interfere, potentially improve, manage toxicity without blocking the effect of the drug etc - 22 Topics
- 58 Posts
-
Last post
to support adding carbon ion …
by Olga View the latest post
-
-
-
Treatment response criteria and evaluation/scanning problems/rare cases
Treatment response to ICI drugs uses different immune related response criteria and often represent the challenge for the radiologist to correctly evaluate the scan - 7 Topics
- 19 Posts
-
Last post
Re: Two cases of falsely diag…
by D.ap View the latest post
-
-
-
treatment discontinuation/re-treatment
How long to treat, when to stop and when to re-start - 0 Topics
- 0 Posts
- No posts
-
-
- Announcements
- Replies
- Views
- Last post
-
- Topics
- Replies
- Views
- Last post
-
- 3 Replies
- 867 Views
-
Last post by D.ap
-
- 0 Replies
- 1439 Views
-
Last post by D.ap
-
- 1 Replies
- 1289 Views
-
Last post by D.ap
-
- 4 Replies
- 3231 Views
-
Last post by D.ap
-
- 0 Replies
- 1313 Views
-
Last post by D.ap
-
- 0 Replies
- 1245 Views
-
Last post by D.ap
-
- 0 Replies
- 1917 Views
-
Last post by D.ap
-
- 0 Replies
- 1929 Views
-
Last post by D.ap
-
- 2 Replies
- 3238 Views
-
Last post by D.ap
-
- 0 Replies
- 2794 Views
-
Last post by D.ap
-
- 48 Replies
- 23126 Views
-
Last post by D.ap
-
- 1 Replies
- 2668 Views
-
Last post by Olga
-
- 2 Replies
- 2673 Views
-
Last post by D.ap
-
- 3 Replies
- 3757 Views
-
Last post by D.ap
-
- 0 Replies
- 3156 Views
-
Last post by Olga
-
- 0 Replies
- 2991 Views
-
Last post by Olga
-
- 0 Replies
- 3302 Views
-
Last post by Olga
-
- 1 Replies
- 3403 Views
-
Last post by D.ap